The Weekly Litigation News Digest is now live. Subscribe now

Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination - EP3294325

The patent EP3294325 was granted to Biontech Cell&Gene Therapies on Jul 26, 2023. The application was originally filed on May 9, 2016 under application number EP16724861A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3294325

BIONTECH CELL&GENE THERAPIES
Application Number
EP16724861A
Filing Date
May 9, 2016
Status
Granted And Under Opposition
Jun 23, 2023
Publication Date
Jul 26, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WITHERS & ROGERSApr 25, 2024TOMBLINGADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003118592
DESCRIPTIONUS2003133939
DESCRIPTIONWO2013143683
INTERNATIONAL-SEARCH-REPORTUS2014099340
INTERNATIONAL-SEARCH-REPORTWO2014144622
INTERNATIONAL-SEARCH-REPORTWO2015150327
OPPOSITIONWO2013143683
OPPOSITIONWO2015150327
OPPOSITIONWO2016180778

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents